Literature DB >> 12901879

A simple and rapid method to determine the zygosity of uPA-transgenic SCID mice.

P Meuleman1, P Vanlandschoot, G Leroux-Roels.   

Abstract

Successful transplantation of xenogeneic hepatocytes into uPA-transgenic SCID mice depends on the zygosity of the recipient mice. Normally, the difference between homozygous and heterozygous animals is determined via a quantitative Southern blot. We sequenced a part of the mouse genome that is eliminated upon integration of the transgene in the genome. Based on that sequence we developed a multiplex PCR that allows the unambiguous discrimination of negative, heterozygous, and homozygous uPA-transgenic SCID mice in a single day procedure. The speed of the procedure is an essential quality because transplantation of xenogeneic hepatocytes into uPA-SCID mice should be done as soon as possible after birth.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12901879     DOI: 10.1016/s0006-291x(03)01388-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant.

Authors:  Artur Kaul; Ilka Woerz; Philip Meuleman; Geert Leroux-Roels; Ralf Bartenschlager
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

2.  Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus.

Authors:  Philip Meuleman; Louis Libbrecht; Stefan Wieland; Rita De Vos; Nagy Habib; Anna Kramvis; Tania Roskams; Geert Leroux-Roels
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

3.  Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents.

Authors:  Koen Vercauteren; Naomi Van Den Eede; Ahmed Atef Mesalam; Sandrine Belouzard; Maria Teresa Catanese; Dorothea Bankwitz; Flossie Wong-Staal; Riccardo Cortese; Jean Dubuisson; Charles M Rice; Thomas Pietschmann; Geert Leroux-Roels; Alfredo Nicosia; Philip Meuleman
Journal:  Hepatology       Date:  2014-07-30       Impact factor: 17.425

4.  In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus.

Authors:  Philip Meuleman; Jens Bukh; Lieven Verhoye; Ali Farhoudi; Thomas Vanwolleghem; Richard Y Wang; Isabelle Desombere; Harvey Alter; Robert H Purcell; Geert Leroux-Roels
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

5.  Griffithsin has antiviral activity against hepatitis C virus.

Authors:  Philip Meuleman; Anna Albecka; Sandrine Belouzard; Koen Vercauteren; Lieven Verhoye; Czeslaw Wychowski; Geert Leroux-Roels; Kenneth E Palmer; Jean Dubuisson
Journal:  Antimicrob Agents Chemother       Date:  2011-09-06       Impact factor: 5.191

6.  Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver disease.

Authors:  Donna N Douglas; Toshiyasu Kawahara; Banu Sis; David Bond; Karl P Fischer; D Lorne J Tyrrell; Jamie T Lewis; Norman M Kneteman
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

7.  Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge.

Authors:  Isabelle Desombere; Samira Fafi-Kremer; Freya Van Houtte; Patrick Pessaux; Ali Farhoudi; Laura Heydmann; Lieven Verhoye; Sarah Cole; Jane A McKeating; Geert Leroux-Roels; Thomas F Baumert; Arvind H Patel; Philip Meuleman
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.298

8.  HCV animal models: a journey of more than 30 years.

Authors:  Philip Meuleman; Geert Leroux-Roels
Journal:  Viruses       Date:  2009-09-02       Impact factor: 5.048

9.  Molecular detection and quantification of Plasmodium falciparum-infected human hepatocytes in chimeric immune-deficient mice.

Authors:  Lander Foquet; Cornelus C Hermsen; Geert-Jan van Gemert; Louis Libbrecht; Robert Sauerwein; Philip Meuleman; Geert Leroux-Roels
Journal:  Malar J       Date:  2013-11-24       Impact factor: 2.979

10.  Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro.

Authors:  Brett D Lindenbach; Philip Meuleman; Alexander Ploss; Thomas Vanwolleghem; Andrew J Syder; Jane A McKeating; Robert E Lanford; Stephen M Feinstone; Marian E Major; Geert Leroux-Roels; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.